Prion Diseases

 

 Permissions and Reprints

Abstract

Prion diseases are a group of diseases caused by abnormally conformed infectious proteins, called prions. They can be sporadic (Jakob-Creutzfeldt disease [JCD]), genetic (genetic JCD, Gerstmann-Sträussler-Scheinker, and familial fatal insomnia), or acquired (kuru, variant JCD, and iatrogenic JCD). The clinical features associated with each form of prion disease, the neuroimaging findings, cerebrospinal fluid markers, and neuropathological findings are reviewed. Sporadic JCD is the most common form of human prion disease, and will be discussed in detail. Genetic prion diseases are caused by mutations in the prion-related protein gene (PRNP), and they are classified based on the mutation, clinical phenotype, and neuropathological features. Acquired prion diseases fortunately are becoming rarer, as awareness of transmission risk has led to implementation of measures to prevent such occurrences, but continued surveillance is necessary to prevent future cases. Treatment and management issues are also discussed.

• References

• 1 Prusiner SB. Prions. Proc Natl Acad Sci U S A 1998; 95 (23) 13363-13383
  CrossrefPubMedGoogle Scholar
• 2 Masters CL. Creutzfeldt-Jakob disease: its origins. Alzheimer Dis Assoc Disord 1989; 3 (1-2) 46-51
  CrossrefPubMedGoogle Scholar
• 3 Masters CL, Harris JO, Gajdusek DC, Gibbs Jr CJ, Bernoulli C, Asher DM. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol 1979; 5 (2) 177-188
  CrossrefPubMedGoogle Scholar
• 4 Ladogana A, Puopolo M, Croes EA , et al. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology 2005; 64 (9) 1586-1591
  CrossrefPubMedGoogle Scholar
• 5 Holman RC, Belay ED, Christensen KY , et al. Human prion diseases in the United States. PLoS ONE 2010; 5 (1) e8521
  CrossrefPubMedGoogle Scholar
• 6 Brown P, Cathala F, Castaigne P, Gajdusek DC. Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann Neurol 1986; 20 (5) 597-602
  CrossrefPubMedGoogle Scholar
• 7 Buganza M, Ferrari S, Cecchini ME, Orrico D, Monaco S, Zanusso G. The oldest old Creutzfeldt-Jakob disease case. J Neurol Neurosurg Psychiatry 2009; 80 (10) 1140-1142
  CrossrefPubMedGoogle Scholar
• 8 Berman PH, Davidson GS, Becker LE. Progressive neurological deterioration in a 14-year-old girl. Pediatr Neurosci 1988; 14 (1) 42-49
  CrossrefPubMedGoogle Scholar
• 9 Corato M, Cereda C, Cova E, Ferrarese C, Ceroni M. Young-onset CJD: age and disease phenotype in variant and sporadic forms. Funct Neurol 2006; 21 (4) 211-215
  PubMedGoogle Scholar
• 10 Kanaani J, Prusiner SB, Diacovo J, Baekkeskov S, Legname G. Recombinant prion protein induces rapid polarization and development of synapses in embryonic rat hippocampal neurons in vitro. J Neurochem 2005; 95 (5) 1373-1386
  CrossrefPubMedGoogle Scholar
• 11 Mallucci GR, White MD, Farmer M , et al. Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice. Neuron 2007; 53 (3) 325-335
  CrossrefPubMedGoogle Scholar
• 12 Colby DW, Prusiner SB. Prions. Cold Spring Harb Perspect Biol 2011; 3 (1) a006833
  CrossrefPubMedGoogle Scholar
• 13 van der Kamp MW, Daggett V. Pathogenic mutations in the hydrophobic core of the human prion protein can promote structural instability and misfolding. J Mol Biol 2010; 404 (4) 732-748
  CrossrefPubMedGoogle Scholar
• 14 Cobb NJ, Surewicz WK. Prion diseases and their biochemical mechanisms. Biochemistry 2009; 48 (12) 2574-2585
  CrossrefPubMedGoogle Scholar
• 15 Parchi P, Castellani R, Capellari S , et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 1996; 39 (6) 767-778
  CrossrefPubMedGoogle Scholar
• 16 Hsiao K, Baker HF, Crow TJ , et al. Linkage of a prion protein missense variant to Gerstmann-Sträussler syndrome. Nature 1989; 338 (6213) 342-345
  CrossrefPubMedGoogle Scholar
• 17 Lloyd SE, Mead S, Collinge J. Genetics of prion diseases. Curr Opin Genet Dev 2013; 23 (3) 345-351
  CrossrefPubMedGoogle Scholar
• 18 Kovács GG, Puopolo M, Ladogana A , et al; EUROCJD. Genetic prion disease: the EUROJCD experience. Hum Genet 2005; 118 (2) 166-174
  CrossrefPubMedGoogle Scholar
• 19 Mastrianni JA. The genetics of prion diseases. Genet Med 2010; 12 (4) 187-195
  CrossrefPubMedGoogle Scholar
• 20 Chapman J, Ben-Israel J, Goldhammer Y, Korczyn AD. The risk of developing Creutzfeldt-Jakob disease in subjects with the PRNP gene codon 200 point mutation. Neurology 1994; 44 (9) 1683-1686
  CrossrefPubMedGoogle Scholar
• 21 Mitrová E, Belay G. Creutzfeldt-Jakob disease with E200K mutation in Slovakia: characterization and development. Acta Virol 2002; 46 (1) 31-39
  PubMedGoogle Scholar
• 22 Parchi P, Giese A, Capellari S , et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999; 46 (2) 224-233
  CrossrefPubMedGoogle Scholar
• 23 Hohler AD, Flynn FG. Onset of Creutzfeldt-Jakob disease mimicking an acute cerebrovascular event. Neurology 2006; 67 (3) 538-539
  CrossrefPubMedGoogle Scholar
• 24 Rabinovici GD, Wang PN, Levin J , et al. First symptom in sporadic Creutzfeldt-Jakob disease. Neurology 2006; 66 (2) 286-287
  CrossrefPubMedGoogle Scholar
• 25 Will RG, Matthews WB. A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970-79. I: Clinical features. J Neurol Neurosurg Psychiatry 1984; 47 (2) 134-140
  CrossrefPubMedGoogle Scholar
• 26 Maltête D, Guyant-Maréchal L, Mihout B, Hannequin D. Movement disorders and Creutzfeldt-Jakob disease: a review. Parkinsonism Relat Disord 2006; 12 (2) 65-71
  CrossrefPubMedGoogle Scholar
• 27 Edler J, Mollenhauer B, Heinemann U , et al. Movement disturbances in the differential diagnosis of Creutzfeldt-Jakob disease. Mov Disord 2009; 24 (3) 350-356
  CrossrefPubMedGoogle Scholar
• 28 Espinosa PS, Bensalem-Owen MK, Fee DB. Sporadic Creutzfeldt-Jakob disease presenting as nonconvulsive status epilepticus case report and review of the literature. Clin Neurol Neurosurg 2010; 112 (6) 537-540
  CrossrefPubMedGoogle Scholar
• 29 Kovács T, Arányi Z, Szirmai I, Lantos PL. Creutzfeldt-Jakob disease with amyotrophy and demyelinating polyneuropathy. Arch Neurol 2002; 59 (11) 1811-1814
  CrossrefPubMedGoogle Scholar
• 30 Paterson RW, Torres-Chae CC, Kuo AL , et al. Differential diagnosis of jakob-creutzfeldt disease. Arch Neurol 2012; 69 (12) 1578-1582
  CrossrefPubMedGoogle Scholar
• 31 Kovacs GG, Seguin J, Quadrio I , et al. Genetic Creutzfeldt-Jakob disease associated with the E200K mutation: characterization of a complex proteinopathy. Acta Neuropathol 2011; 121 (1) 39-57
  CrossrefPubMedGoogle Scholar
• 32 Esiri MM, Gordon WI, Collinge J, Patten JS. Peripheral neuropathy in Creutzfeldt-Jakob disease. Neurology 1997; 48 (3) 784
  PubMedGoogle Scholar
• 33 Antoine JC, Laplanche JL, Mosnier JF, Beaudry P, Chatelain J, Michel D. Demyelinating peripheral neuropathy with Creutzfeldt-Jakob disease and mutation at codon 200 of the prion protein gene. Neurology 1996; 46 (4) 1123-1127
  CrossrefPubMedGoogle Scholar
• 34 Chapman J, Brown P, Goldfarb LG, Arlazoroff A, Gajdusek DC, Korczyn AD. Clinical heterogeneity and unusual presentations of Creutzfeldt-Jakob disease in Jewish patients with the PRNP codon 200 mutation. J Neurol Neurosurg Psychiatry 1993; 56 (10) 1109-1112
  CrossrefPubMedGoogle Scholar
• 35 Pocchiari M, Puopolo M, Croes EA , et al. Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain 2004; 127 (Pt 10) 2348-2359
  CrossrefPubMedGoogle Scholar
• 36 WHO. Global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies: Report of a WHO Consultation Geneva, Switzerland, 9–11 February 1998. Geneva, Switzerland: World Health Organization; 1998
  Google Scholar
• 37 Geschwind MD, Josephs KA, Parisi JE, Keegan BM. A 54-year-old man with slowness of movement and confusion. Neurology 2007; 69 (19) 1881-1887
  CrossrefPubMedGoogle Scholar
• 38 Zerr I, Kallenberg K, Summers DM , et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 2009; 132 (Pt 10) 2659-2668
  CrossrefPubMedGoogle Scholar
• 39 Puoti G, Bizzi A, Forloni G, Safar JG, Tagliavini F, Gambetti P. Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol 2012; 11 (7) 618-628
  CrossrefPubMedGoogle Scholar
• 40 Parchi P, Capellari S, Chin S , et al. A subtype of sporadic prion disease mimicking fatal familial insomnia. Neurology 1999; 52 (9) 1757-1763
  CrossrefPubMedGoogle Scholar
• 41 Cali I, Castellani R, Alshekhlee A , et al. Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: its effect on the phenotype and prion-type characteristics. Brain 2009; 132 (Pt 10) 2643-2658
  CrossrefPubMedGoogle Scholar
• 42 Parchi P, Strammiello R, Notari S , et al. Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification. Acta Neuropathol 2009; 118 (5) 659-671
  CrossrefPubMedGoogle Scholar
• 43 Appleby BS, Appleby KK, Crain BJ, Onyike CU, Wallin MT, Rabins PV. Characteristics of established and proposed sporadic Creutzfeldt-Jakob disease variants. Arch Neurol 2009; 66 (2) 208-215
  CrossrefPubMedGoogle Scholar
• 44 Gambetti P, Kong Q, Zou W, Parchi P, Chen SG. Sporadic and familial CJD: classification and characterisation. Br Med Bull 2003; 66 (1) 213-239
  CrossrefPubMedGoogle Scholar
• 45 Worrall BB, Rowland LP, Chin SS, Mastrianni JA. Amyotrophy in prion diseases. Arch Neurol 2000; 57 (1) 33-38
  CrossrefPubMedGoogle Scholar
• 46 Jansen C, Head MW, Rozemuller AJ, Ironside JW. Panencephalopathic Creutzfeldt-Jakob disease in the Netherlands and the UK: clinical and pathological characteristics of nine patients. Neuropathol Appl Neurobiol 2009; 35 (3) 272-282
  CrossrefPubMedGoogle Scholar
• 47 Mizutani T, Okumura A, Oda M, Shiraki H. Panencephalopathic type of Creutzfeldt-Jakob disease: primary involvement of the cerebral white matter. J Neurol Neurosurg Psychiatry 1981; 44 (2) 103-115
  CrossrefPubMedGoogle Scholar
• 48 Zou WQ, Puoti G, Xiao X , et al. Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Ann Neurol 2010; 68 (2) 162-172
  CrossrefPubMedGoogle Scholar
• 49 Vitali P, Maccagnano E, Caverzasi E , et al. Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology 2011; 76 (20) 1711-1719
  CrossrefPubMedGoogle Scholar
• 50 Shiga Y, Miyazawa K, Sato S , et al. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology 2004; 63 (3) 443-449
  CrossrefPubMedGoogle Scholar
• 51 Shiga Y, Miyazawa K, Sato S , et al. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology 2004; 63 (3) 443-449
  CrossrefPubMedGoogle Scholar
• 52 Young GS, Geschwind MD, Fischbein NJ , et al. Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol 2005; 26 (6) 1551-1562
  PubMedGoogle Scholar
• 53 Geschwind MD, Potter CA, Sattavat M , et al. Correlating DWI MRI with pathologic and other features of Jakob-Creutzfeldt disease. Alzheimer Dis Assoc Disord 2009; 23 (1) 82-87
  CrossrefPubMedGoogle Scholar
• 54 Letourneau-Guillon L, Wada R, Kucharczyk W. Imaging of prion diseases. J Magn Reson Imaging 2012; 35 (5) 998-1012
  CrossrefPubMedGoogle Scholar
• 55 Carswell C, Thompson A, Lukic A , et al. MRI findings are often missed in the diagnosis of Creutzfeldt-Jakob disease. BMC Neurol 2012; 12 (1) 153
  CrossrefPubMedGoogle Scholar
• 56 Geschwind MD, Kuryan C, Cattaruzza T, Vitali P, DeArmond S, Wong K. Brain MRI in sporadic Jakob-Creutzfeldt disease is often misread. Neurology 2010; 74 (Suppl. 02) A213
  PubMedGoogle Scholar
• 57 Muayqil T, Gronseth G, Camicioli R. Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease: report of the guideline development subcommittee of the American Academy of Neurology. Neurology 2012; 79 (14) 1499-1506
  CrossrefPubMedGoogle Scholar
• 58 Coulthart MB, Jansen GH, Olsen E , et al. Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study. BMC Neurol 2011; 11: 133
  CrossrefPubMedGoogle Scholar
• 59 van Harten AC, Kester MI, Visser PJ , et al. Tau and p-tau as CSF biomarkers in dementia: a meta-analysis. Clin Chem Lab Med 2011; 49 (3) 353-366
  CrossrefPubMedGoogle Scholar
• 60 Sanchez-Juan P, Green A, Ladogana A , et al. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 2006; 67 (4) 637-643
  CrossrefPubMedGoogle Scholar
• 61 Deisenhammer F, Egg R, Giovannoni G , et al; EFSN. EFNS guidelines on disease-specific CSF investigations. Eur J Neurol 2009; 16 (6) 760-770
  CrossrefPubMedGoogle Scholar
• 62 Geschwind MD, Martindale J, Miller D , et al. Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. Arch Neurol 2003; 60 (6) 813-816
  CrossrefPubMedGoogle Scholar
• 63 Stoeck K, Sanchez-Juan P, Gawinecka J , et al. Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years. Brain 2012; 135 (Pt 10) 3051-3061
  CrossrefPubMedGoogle Scholar
• 64 Steinhoff BJ, Zerr I, Glatting M, Schulz-Schaeffer W, Poser S, Kretzschmar HA. Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease. Ann Neurol 2004; 56 (5) 702-708
  CrossrefPubMedGoogle Scholar
• 65 Tschampa HJ, Neumann M, Zerr I , et al. Patients with Alzheimer's disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2001; 71 (1) 33-39
  CrossrefPubMedGoogle Scholar
• 66 Seipelt M, Zerr I, Nau R , et al. Hashimoto's encephalitis as a differential diagnosis of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 1999; 66 (2) 172-176
  CrossrefPubMedGoogle Scholar
• 67 Budka H. Neuropathology of prion diseases. Br Med Bull 2003; 66: 121-130
  CrossrefPubMedGoogle Scholar
• 68 Venneti S. Prion diseases. Clin Lab Med 2010; 30 (1) 293-309
  CrossrefPubMedGoogle Scholar
• 69 Capellari S, Strammiello R, Saverioni D, Kretzschmar H, Parchi P. Genetic Creutzfeldt-Jakob disease and fatal familial insomnia: insights into phenotypic variability and disease pathogenesis. Acta Neuropathol 2011; 121 (1) 21-37
  CrossrefPubMedGoogle Scholar
• 70 Brown K, Mastrianni JA. The prion diseases. J Geriatr Psychiatry Neurol 2010; 23 (4) 277-298
  CrossrefPubMedGoogle Scholar
• 71 Arata H, Takashima H, Hirano R , et al. Early clinical signs and imaging findings in Gerstmann-Sträussler-Scheinker syndrome (Pro102Leu). Neurology 2006; 66 (11) 1672-1678
  CrossrefPubMedGoogle Scholar
• 72 Goldfarb LG, Petersen RB, Tabaton M , et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science 1992; 258 (5083) 806-808
  CrossrefPubMedGoogle Scholar
• 73 Will RG. Acquired prion disease: iatrogenic CJD, variant CJD, kuru. Br Med Bull 2003; 66: 255-265
  CrossrefPubMedGoogle Scholar
• 74 Collinge J, Whitfield J, McKintosh E , et al. Kuru in the 21st century—an acquired human prion disease with very long incubation periods. Lancet 2006; 367 (9528) 2068-2074
  CrossrefPubMedGoogle Scholar
• 75 Brown P, Brandel JP, Preece M, Sato T. Iatrogenic Creutzfeldt-Jakob disease: the waning of an era. Neurology 2006; 67 (3) 389-393
  CrossrefPubMedGoogle Scholar
• 76 Brown P, Brandel JP, Sato T , et al. Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg Infect Dis 2012; 18 (6) 901-907
  CrossrefPubMedGoogle Scholar
• 77 World Health Organization. WHO Guidelines on Tissue Infectivity Distribution in Transmissible Spongiform Encephalopathies; Report of the WHO Consultation in Geneva 14–16 September 2005. Geneva, Switzerland: Quality and Safety of Plasma Derivatives and Related Substances, Department of Medicines Policy and Standards, Health Technology and Pharmaceuticals Cluster, World Health Organization; 2006
  Google Scholar
• 78 Will RG, Ironside JW, Zeidler M , et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347 (9006) 921-925
  CrossrefPubMedGoogle Scholar
• 79 Norrby E. Prions and protein-folding diseases. J Intern Med 2011; 270 (1) 1-14
  CrossrefPubMedGoogle Scholar
• 80 Kaski D, Mead S, Hyare H , et al. Variant CJD in an individual heterozygous for PRNP codon 129. Lancet 2009; 374 (9707) 2128
  CrossrefPubMedGoogle Scholar
• 81 Heath CA, Cooper SA, Murray K , et al. Validation of diagnostic criteria for variant Creutzfeldt-Jakob disease. Ann Neurol 2010; 67 (6) 761-770
  PubMedGoogle Scholar
• 82 Binelli S, Agazzi P, Giaccone G , et al. Periodic electroencephalogram complexes in a patient with variant Creutzfeldt-Jakob disease. Ann Neurol 2006; 59 (2) 423-427
  CrossrefPubMedGoogle Scholar
• 83 Collie DA, Summers DM, Sellar RJ , et al. Diagnosing variant Creutzfeldt-Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases. AJNR Am J Neuroradiol 2003; 24 (8) 1560-1569
  PubMedGoogle Scholar
• 84 Petzold GC, Westner I, Bohner G, Einhäupl KM, Kretzschmar HA, Valdueza JM. False-positive pulvinar sign on MRI in sporadic Creutzfeldt-Jakob disease. Neurology 2004; 62 (7) 1235-1236
  CrossrefPubMedGoogle Scholar
• 85 Fulbright RK, Hoffmann C, Lee H, Pozamantir A, Chapman J, Prohovnik I. MR imaging of familial Creutzfeldt-Jakob disease: a blinded and controlled study. AJNR Am J Neuroradiol 2008; 29 (9) 1638-1643
  CrossrefPubMedGoogle Scholar
• 86 Will R. Variant Creutzfeldt-Jakob disease. Folia Neuropathol 2004; 42 (Suppl A ): 77-83
  PubMedGoogle Scholar
• 87 Llewelyn CA, Hewitt PE, Knight RS , et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004; 363 (9407) 417-421
  CrossrefPubMedGoogle Scholar
• 88 Dorsey K, Zou S, Schonberger LB , et al. Lack of evidence of transfusion transmission of Creutzfeldt-Jakob disease in a US surveillance study. Transfusion 2009; 49 (5) 977-984
  CrossrefPubMedGoogle Scholar
• 89 Ironside JW. Variant Creutzfeldt-Jakob disease: an update. Folia Neuropathol 2012; 50 (1) 50-56
  PubMedGoogle Scholar
• 90 Hilton DA, Ghani AC, Conyers L , et al. Accumulation of prion protein in tonsil and appendix: review of tissue samples. BMJ 2002; 325 (7365) 633-634
  CrossrefPubMedGoogle Scholar
• 91 Hilton DA, Ghani AC, Conyers L , et al. Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 2004; 203 (3) 733-739
  CrossrefPubMedGoogle Scholar
• 92 Paterson RW, Takada LT, Geschwind MD. Diagnosis and treatment of rapidly progressive dementias. Neurol Clin Pract 2012; 2 (3) 187-200
  CrossrefPubMedGoogle Scholar
• 93 Kranitz FJ, Simpson DM. Using non-pharmacological approaches for CJD patient and family support as provided by the CJD foundation and CJD insight. CNS Neurol Disord Drug Targets 2009; 8 (5) 372-379
  CrossrefPubMedGoogle Scholar
• 94 Chitravas N, Jung RS, Kofskey DM , et al. Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease. Ann Neurol 2011; 70 (3) 437-444
  CrossrefPubMedGoogle Scholar
• 95 Atarashi R, Satoh K, Sano K , et al. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med 2011; 17 (2) 175-178
  CrossrefPubMedGoogle Scholar
• 96 Edgeworth JA, Farmer M, Sicilia A , et al. Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay. Lancet 2011; 377 (9764) 487-493
  CrossrefPubMedGoogle Scholar
• 97 Geschwind MD. Clinical trials for prion disease: difficult challenges, but hope for the future. Lancet Neurol 2009; 8 (4) 304-306
  CrossrefPubMedGoogle Scholar